Kianmehr Anvarsadat, Qujeq Durdi, Bagheri Abouzar, Mahrooz Abdolkarim
Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Crit Rev Clin Lab Sci. 2022 Jan;59(1):40-53. doi: 10.1080/10408363.2021.1974334. Epub 2021 Sep 15.
As a simple monolayer, vascular endothelial cells can respond to physicochemical stimuli. In addition to promoting the formation of foam cells, oxidized low-density lipoprotein (ox-LDL) contributes to the atherosclerotic process through different mechanisms, including endothelial cell dysfunction. As conserved noncoding RNAs, microRNAs (miRNAs) naturally lie in different genomic positions and post-transcriptionally regulate the expression of many genes. They participate in integrated networks formed under stress to maintain cellular homeostasis, vascular inflammation, and metabolism. These small RNAs constitute therapeutic targets in different diseases, including atherosclerosis, and their role as biomarkers is crucial given their detectability even years before the emergence of diseases. This review was performed to investigate the role of ox-LDL-regulated miRNAs in atherosclerosis, their molecular mechanisms, and their application as biomarkers of vascular endothelial cell dysfunction.
作为简单的单层细胞,血管内皮细胞能够对物理化学刺激做出反应。除了促进泡沫细胞的形成外,氧化型低密度脂蛋白(ox-LDL)还通过不同机制,包括内皮细胞功能障碍,促进动脉粥样硬化进程。作为保守的非编码RNA,微小RNA(miRNA)天然存在于不同的基因组位置,并在转录后调节许多基因的表达。它们参与应激状态下形成的整合网络,以维持细胞内稳态、血管炎症和代谢。这些小RNA构成了包括动脉粥样硬化在内的不同疾病的治疗靶点,鉴于它们甚至在疾病出现前数年就具有可检测性,其作为生物标志物的作用至关重要。本综述旨在研究ox-LDL调节的miRNA在动脉粥样硬化中的作用、其分子机制及其作为血管内皮细胞功能障碍生物标志物的应用。